Wenjia Qu

384 Victoria St
Sydney, NSW 2010, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer.

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer.

Journal: BJUI compass

Published: August 14, 2024

Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling.

Characterisation and reproducibility of the HumanMethylationEPIC v2.0 BeadChip for DNA methylation profiling.

Journal: BMC genomics

Published: October 12, 2023

The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.

The potential of epigenetic therapy to target the 3D epigenome in endocrine-resistant breast cancer.

Journal: Nature structural & molecular biology

Published: December 13, 2022

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality.

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality.

Journal: Clinical and translational medicine

Published: March 24, 2022

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).

GUIDE: a randomised non-comparative phase II trial of biomarker-driven intermittent docetaxel versus standard-of-care docetaxel in metastatic castration-resistant prostate cancer (clinical trial protocol).

Journal: Therapeutic advances in medical oncology

Published: February 07, 2022

Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels.

Comprehensive evaluation of targeted multiplex bisulphite PCR sequencing for validation of DNA methylation biomarker panels.

Journal: Clinical epigenetics

Published: February 18, 2020

Methylome and transcriptome maps of human visceral and subcutaneous adipocytes reveal key epigenetic differences at developmental genes.

Methylome and transcriptome maps of human visceral and subcutaneous adipocytes reveal key epigenetic differences at developmental genes.

Journal: Scientific reports

Published: April 09, 2019

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.

Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine-resistant breast cancer.

Journal: Nature communications

Published: December 02, 2018

Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements.

Evaluation of cross-platform and interlaboratory concordance via consensus modelling of genomic measurements.

Journal: Bioinformatics (Oxford, England)

Published: May 02, 2018

Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial.

Serum Free Methylated Glutathione S-transferase 1 DNA Levels, Survival, and Response to Docetaxel in Metastatic, Castration-resistant Prostate Cancer: Post Hoc Analyses of Data from a Phase 3 Trial.

Journal: European urology

Published: April 15, 2018

Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten.

Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten.

Journal: Epigenetics & chromatin

Published: February 09, 2018

Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer.

Replication timing and epigenome remodelling are associated with the nature of chromosomal rearrangements in cancer.

Journal: Nature communications

Published: January 23, 2018

Showing 1-12 of 17

Last Updated: 09/26/2026